January 30, 2019
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Read More
December 10, 2018
A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy
Read More
X